Tirzepatide

Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist of

Sources
Draw Volume
0.500mL
U-100 Scale
50mark
Concentration
5,000mcg/mL
Doses / Vial
2doses
Vial Total
5mg
Waste / Vial
0mcg
Scale Capacity
100U-100 max · 1mL
Recommended Schedule
M
T
W
T
F
S
S
FrequencyOnce weekly
TimingAny time, consistent day
CycleOngoing
NoteStart 2.5mg weekly for 4 weeks, then increase to 5mg. Compounded vials require reconstitution.

Calculation audit

Entered vial mass
5 mg
Entered diluent volume
1 mL
Calculated concentration
5,000 mcg/mL

Mass ÷ volume = concentration

(5 mg × 1,000) ÷ 1 mL = 5,000 mcg/mL

These are unverified inputs and arithmetic—not preparation instructions. This tool cannot identify the product, confirm label content, choose a diluent, establish compatibility, sterility, stability, route, measurable precision, or an appropriate dose. Follow the exact product instructions and licensed clinical or pharmacy guidance. Review the stability and diluent guide and U-100 scale guide.

Supply Planner

1x / week for weeks

·
·
2vials
4 doses14 days/vial
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month

Arithmetic only. A “U-100 scale” has 100 labeled units per mL; its number is not an insulin dose, a prescription, or proof that the entered volume can be measured on the selected device. Verify the exact product, concentration, diluent, device graduations, and instructions with a prescriber or pharmacist. Read the syringe-scale guide.

Arithmetic onlyU-100 scaleVerify exact productNot preparation or administration guidance